Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan and capecitabine, work in different
ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may help
capecitabine kill more tumor cells by making tumor cells more sensitive to the drug.
PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan and
capecitabine in treating women with advanced breast cancer.